Latest Injective (INJ) News Update

Résumé détaillé

Chen Backs Tokenization’s Long Game (11 November 2026) – Chen cited tokenization and round-the-clock trading as long-term adoption drivers despite near-term macro uncertainty.…

Injective’s week has forward motion and speed bumps; here are the latest news:

Overview: Injective CEO Eric Chen described the market pullback as a correction amid macro uncertainty. He pointed to institutional adoption, tokenized assets and 24-hour trading as longer-term forces, and referenced the recently launched staked INJ ETF.

What this means: This is cautiously positive for INJ because these developments could widen institutional access and use cases. But adoption takes time, and macro uncertainty may keep weighing on sentiment.

Overview: Injective’s community administrator said the pause was a coordinated upgrade-readiness test with validators. Bithumb suspended INJ deposits and withdrawals until network operations stabilize; a larger mainnet upgrade was scheduled for 17 November.

What this means: This is a near-term operational risk for users moving INJ, even if the pause is planned. Watch for confirmation that block production and exchange transfers have resumed.

Overview: Canary Capital’s INJC began trading on Nasdaq on 5 November, providing brokerage-account exposure to INJ and staking. The fund’s rewards accrue to its net asset value; staking returns are not guaranteed.

What this means: This is potentially positive for access, but the product does not reduce INJ price volatility or ensure investor inflows.

Injective’s institutional-access story is advancing, while the network pause makes operational follow-through important. Will block production and exchange transfers normalize ahead of the scheduled upgrade?

Overview: Injective introduced a dedicated transaction route for approved banks and enterprises. It provides an early execution response, but transactions are not final until the validator network confirms them.

Début de l'article, extrait de CoinMarketCap. Pour lire la suite, ouvrez l'article chez le média.